Angiotensin-(1-7) inhibits growth of cardiac myocytes through activation of the mas receptor

被引:273
作者
Tallant, EA [1 ]
Ferrario, CM [1 ]
Gallagher, PE [1 ]
机构
[1] Wake Forest Univ, Bowman Gray Sch Med, Hypertens & Vasc Dis Ctr, Winston Salem, NC 27157 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 2005年 / 289卷 / 04期
关键词
cardiac hypertrophy; mitogen-activated protein kinases;
D O I
10.1152/ajpheart.00941.2004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Peptide hormones such as ANG II and endothelin contribute to cardiac remodeling after myocardial infarction by stimulating myocyte hypertrophy and myofibroblast proliferation. In contrast, angiotensin( 1 - 7) [ANG-(1 - 7)] infusion after myocardial infarction reduced myocyte size and attenuated ventricular dysfunction and remodeling. We measured the effect of ANG-( 1 - 7) on protein and DNA synthesis in cultured neonatal rat myocytes to assess the role of the heptapeptide in cell growth. ANG-( 1 - 7) significantly attenuated either fetal bovine serum- or endothelin-1-stimulated [H-3] leucine incorporation into myocytes with no effect on [ 3H] thymidine incorporation. [D-Ala(7)]- ANG-(1 - 7), the selective ANG type 1 - 7 (AT(1-7)) receptor antagonist, blocked the ANG-( 1 - 7)- mediated reduction in protein synthesis in cardiac myocytes, whereas the AT(1) and AT(2) angiotensin peptide receptors were ineffective. Serum-stimulated ERK1/ERK2 mitogen-activated protein kinase activity was significantly decreased by ANG-( 1 - 7) in myocytes, a response that was also blocked by [D-Ala(7)]-ANG-(1 - 7). Both rat heart and cardiac myocytes express the mRNA for the mas receptor, and a 59-kDa immunoreactive protein was identified in both extracts of rat heart and cultured myocytes by Western blot hybridization with the use of an antibody to mas, an ANG-( 1 - 7) receptor. Transfection of cultured myocytes with an antisense oligonucleotide to the mas receptor blocked the ANG-( 1 7)- mediated inhibition of serum- stimulated MAPK activation, whereas a sense oligonucleotide was ineffective. These results suggest that ANG-( 1 - 7) reduces the growth of cardiomyocytes through activation of the mas receptor. Because ANG-( 1 - 7) is elevated after treatment with angiotensin-converting enzyme inhibitors or AT1 receptor blockers, ANG-( 1 - 7) may contribute to their beneficial effects on cardiac dysfunction and ventricular remodeling after myocardial infarction.
引用
收藏
页码:H1560 / H1566
页数:7
相关论文
共 53 条
[1]   Specific role of the extracellular signal-regulated kinase pathway in angiotensin II-induced cardiac hypertrophy in vitro [J].
Aoki, H ;
Richmond, M ;
Izumo, S ;
Sadoshima, J .
BIOCHEMICAL JOURNAL, 2000, 347 :275-284
[2]   Cardiac angiotensin-(1-7) in ischemic cardiomyopathy [J].
Averill, DB ;
Ishiyama, Y ;
Chappell, MC ;
Ferrario, CM .
CIRCULATION, 2003, 108 (17) :2141-2146
[3]   ANTIHYPERTENSIVE ACTIONS OF ANGIOTENSIN-(1-7) IN SPONTANEOUSLY HYPERTENSIVE RATS [J].
BENTER, IF ;
FERRARIO, CM ;
MORRIS, M ;
DIZ, DI .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1995, 269 (01) :H313-H319
[4]   CARDIOVASCULAR ACTIONS OF ANGIOTENSIN(1-7) [J].
BENTER, IF ;
DIZ, DI ;
FERRARIO, CM .
PEPTIDES, 1993, 14 (04) :679-684
[5]   Role of angiotensin-(1-7) in the modulation of the baroreflex in renovascular hypertensive rats [J].
Britto, RR ;
Santos, RAS ;
FagundesMoura, CR ;
Khosla, MC ;
CampagnoleSantos, MJ .
HYPERTENSION, 1997, 30 (03) :549-556
[6]   Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide [J].
Brosnihan, KB ;
Li, P ;
Ferrario, CM .
HYPERTENSION, 1996, 27 (03) :523-528
[7]   Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death [J].
Bueno, OF ;
Molkentin, JD .
CIRCULATION RESEARCH, 2002, 91 (09) :776-781
[8]   The dual-specificity phosphatase MKP-1 limits the cardiac hypertrophic response in vitro and in vivo [J].
Bueno, OF ;
De Windt, LJ ;
Lim, HW ;
Tymitz, KM ;
Witt, SA ;
Kimball, TR ;
Molkentin, JD .
CIRCULATION RESEARCH, 2001, 88 (01) :88-96
[9]   The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice [J].
Bueno, OF ;
De Windt, LJ ;
Tymitz, KM ;
Witt, SA ;
Kimball, TR ;
Klevitsky, R ;
Hewett, TE ;
Jones, SP ;
Lefer, DJ ;
Peng, CF ;
Kitsis, RN ;
Molkentin, JD .
EMBO JOURNAL, 2000, 19 (23) :6341-6350
[10]   NEPHRECTOMY, CONVERTING-ENZYME INHIBITION, AND ANGIOTENSIN PEPTIDES [J].
CAMPBELL, DJ ;
KLADIS, A ;
DUNCAN, AM .
HYPERTENSION, 1993, 22 (04) :513-522